{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T10:07:53Z","timestamp":1781258873889,"version":"3.54.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,23]],"date-time":"2023-06-23T00:00:00Z","timestamp":1687478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,23]],"date-time":"2023-06-23T00:00:00Z","timestamp":1687478400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006390","name":"University of Lausanne","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006390","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cardiovascular events such as myocardial infarction and stroke are life-threatening complications associated with Neurofibromatosis type 1 (NF1). As previous studies observed an association between cardiovascular events and the loss of circadian variations of blood pressure, we investigated the 24\u00a0h circadian rhythm of blood pressure (BP) in 24 NF1 patients (10 males and 14 females, with a mean age of 39.5 years\u2009\u00b1\u200914 years) by using ambulatory blood pressure monitoring (ABPM).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Only one-third of the patient were dippers, 50% were non-dippers, and 17% were risers. Reduced variability of systolic and diastolic nocturnal blood pressure was observed in NF1 patients compared with several studies of normotensive individuals (p\u2009=\u20090.024). In NF1 patients, the blunted systolic nocturnal decline was significantly associated with the number of neurofibromas (p\u2009=\u20090.049) and the presence of a plexiform neurofibroma (p\u2009=\u20090.020).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Most NF1 patients in this study showed a \u201cnon-dipper\u201d pattern with a blunted nocturnal BP decline, which is considered an independent risk factor for cardiovascular events in normotensive and hypertensive individuals. Periodic monitoring of BP should be included in NF1 follow-up guidelines to diagnose masked hypertension or a non-dipper\/riser pattern which would significantly increase the morbidity and mortality of NF1 patients to implement therapeutic strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-023-02766-7","type":"journal-article","created":{"date-parts":[[2023,6,24]],"date-time":"2023-06-24T01:47:09Z","timestamp":1687571229000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Blunted circadian variation of blood pressure in individuals with neurofibromatosis type 1"],"prefix":"10.1186","volume":"18","author":[{"given":"Ana M. Cieza","family":"Rivera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tania","family":"Fern\u00e1ndez-Villa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicente","family":"Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0618-1549","authenticated-orcid":false,"given":"Isis","family":"Atallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,23]]},"reference":[{"issue":"2","key":"2766_CR1","doi-asserted-by":"publisher","first-page":"136","DOI":"10.2340\/0001555575136140","volume":"75","author":"M Zoller","year":"1995","unstructured":"Zoller M, Rembeck B, Akesson HO, Angervall L. Life expectancy, mortality and prognostic factors in neurofibromatosis type 1. A twelve-year follow-up of an epidemiological study in Goteborg, Sweden. Acta Derm Venereol. 1995;75(2):136\u201340.","journal-title":"Acta Derm Venereol"},{"key":"2766_CR2","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1212\/WNL.55.2.325","volume":"55","author":"DHG Friedman","year":"2000","unstructured":"Friedman DHG, Mia, MacCollin. Neurofibromatosis: phenotype, natural history and pathogenesis. Neurology. 2000;55:325.","journal-title":"Neurology"},{"issue":"4","key":"2766_CR3","first-page":"e14658","volume":"13","author":"M Faris","year":"2021","unstructured":"Faris M, Baliss M, Coni R, Nambudiri V. Severe hypertension leading to hemorrhagic stroke in neurofibromatosis type 1. Cureus. 2021;13(4):e14658.","journal-title":"Cureus"},{"issue":"6","key":"2766_CR4","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1161\/01.HYP.4.6.894","volume":"4","author":"GP Guthrie Jr","year":"1982","unstructured":"Guthrie GP Jr, Tibbs PA, McAllister RG Jr, Stevens RK, Clark DB. Hypertension and neurofibromatosis. Case report. Hypertension. 1982;4(6):894\u20137.","journal-title":"Hypertension"},{"key":"2766_CR5","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1056\/NEJM196507292730505","volume":"273","author":"Currarino MHaG","year":"1965","unstructured":"Currarino MHaG. Vascular lesions causing hypertension in neurofibromatosis. N Engl J Med. 1965;273:248\u201352.","journal-title":"N Engl J Med"},{"issue":"1","key":"2766_CR6","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/sj.jhh.1000739","volume":"13","author":"FP Cappuccio","year":"1999","unstructured":"Cappuccio FP, Allan R, Barron J, MacGregor GA, Murday VA. Secondary hypertension and clinical genetics: usual presentation with unusual diagnosis. J Hum Hypertens. 1999;13(1):79\u201380.","journal-title":"J Hum Hypertens"},{"issue":"8068","key":"2766_CR7","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/S0140-6736(78)92998-7","volume":"1","author":"MW Millar-Craig","year":"1978","unstructured":"Millar-Craig MW, Bishop CN, Raftery EB. Circadian variation of blood-pressure. Lancet. 1978;1(8068):795\u20137.","journal-title":"Lancet"},{"issue":"Suppl 1","key":"2766_CR8","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1097\/00126097-200005001-00004","volume":"5","author":"WB White","year":"2000","unstructured":"White WB. Ambulatory blood pressure monitoring: dippers compared with non-dippers. Blood Press Monit. 2000;5(Suppl 1):17\u201323.","journal-title":"Blood Press Monit"},{"issue":"7","key":"2766_CR9","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1097\/00004872-200018070-00005","volume":"18","author":"T Ohkubo","year":"2000","unstructured":"Ohkubo T, Hozawa A, Nagai K, Kikuya M, Tsuji I, Ito S, et al. Prediction of stroke by ambulatory blood pressure monitoring versus screening blood pressure measurements in a general population: the Ohasama study. J Hypertens. 2000;18(7):847\u201354.","journal-title":"J Hypertens"},{"issue":"4","key":"2766_CR10","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1097\/HJH.0b013e328322cd62","volume":"27","author":"E Dolan","year":"2009","unstructured":"Dolan E, Stanton AV, Thom S, Caulfield M, Atkins N, McInnes G, et al. Ambulatory blood pressure monitoring predicts cardiovascular events in treated hypertensive patients\u2013an anglo-scandinavian cardiac outcomes trial substudy. J Hypertens. 2009;27(4):876\u201385.","journal-title":"J Hypertens"},{"issue":"2","key":"2766_CR11","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1081\/CEH-120028556","volume":"26","author":"K Kario","year":"2004","unstructured":"Kario K, Shimada K. Risers and extreme-dippers of nocturnal blood pressure in hypertension: antihypertensive strategy for nocturnal blood pressure. Clin Exp Hypertens. 2004;26(2):177\u201389.","journal-title":"Clin Exp Hypertens"},{"issue":"21","key":"2766_CR12","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1056\/NEJM198511213132103","volume":"313","author":"JE Muller","year":"1985","unstructured":"Muller JE, Stone PH, Turi ZG, Rutherford JD, Czeisler CA, Parker C, et al. Circadian variation in the frequency of onset of acute myocardial infarction. N Engl J Med. 1985;313(21):1315\u201322.","journal-title":"N Engl J Med"},{"issue":"11","key":"2766_CR13","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1016\/S0002-9149(97)00181-1","volume":"79","author":"MC Cohen","year":"1997","unstructured":"Cohen MC, Rohtla KM, Lavery CE, Muller JE, Mittleman MA. Meta-analysis of the morning excess of acute myocardial infarction and sudden cardiac death. Am J Cardiol. 1997;79(11):1512\u20136.","journal-title":"Am J Cardiol"},{"issue":"5","key":"2766_CR14","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1161\/01.STR.29.5.992","volume":"29","author":"WJ Elliott","year":"1998","unstructured":"Elliott WJ. Circadian variation in the timing of stroke onset: a meta-analysis. Stroke. 1998;29(5):992\u20136.","journal-title":"Stroke"},{"issue":"5","key":"2766_CR15","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1161\/01.HYP.0000215364.56025.b9","volume":"47","author":"P Verdecchia","year":"2006","unstructured":"Verdecchia P, Angeli F, Staessen JA. Compared with whom? Addressing the prognostic value of ambulatory blood pressure categories. Hypertension. 2006;47(5):820\u20131.","journal-title":"Hypertension"},{"issue":"9","key":"2766_CR16","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1038\/sj.ki.5002130","volume":"71","author":"AJ Peixoto","year":"2007","unstructured":"Peixoto AJ, White WB. Circadian blood pressure: clinical implications based on the pathophysiology of its variability. Kidney Int. 2007;71(9):855\u201360.","journal-title":"Kidney Int"},{"issue":"4","key":"2766_CR17","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s00467-003-1397-5","volume":"19","author":"G Lama","year":"2004","unstructured":"Lama G, Graziano L, Calabrese E, Grassia C, Rambaldi PF, Cioce F, et al. Blood pressure and cardiovascular involvement in children with neurofibromatosis type1. Pediatr Nephrol. 2004;19(4):413\u20138.","journal-title":"Pediatr Nephrol"},{"key":"2766_CR18","doi-asserted-by":"publisher","first-page":"58","DOI":"10.13078\/jsm.200004","volume":"17","author":"ZYS Yal\u0131m","year":"2020","unstructured":"Yal\u0131m ZYS. Relationship of Non-Dipper and Reverse-Dipper Pattern with Sleep Quality in Normotensive Patients. J Sleep Med. 2020;17:58\u201365.","journal-title":"J Sleep Med"},{"key":"2766_CR19","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1097\/01.hjh.0000378446.46800.6d","volume":"28","author":"PDLC Aranda","year":"2010","unstructured":"Aranda PDLC, Fernandez-Garcia JJ, Ribo-Crusat JC, De Miguel F, Perez-Vidal A, Alvarez-Lipe S, Segura R, Gorostidi J, De La Sierra M, Banegas A, Ruilope JR. Measuring cardiovasculare risk in normotensive people: impact of a non dipper pattern pf blood pressure: PP.3.122. J Hypertens. 2010;28:84.","journal-title":"J Hypertens"},{"issue":"1\u20132","key":"2766_CR20","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3109\/07420528.2012.701127","volume":"30","author":"RC Hermida","year":"2013","unstructured":"Hermida RC, Ayala DE, Mojon A, Fernandez JR. Blunted sleep-time relative blood pressure decline increases cardiovascular risk independent of blood pressure level\u2013the \u201cnormotensive non-dipper\u201d paradox. Chronobiol Int. 2013;30(1\u20132):87\u201398.","journal-title":"Chronobiol Int"},{"issue":"4","key":"2766_CR21","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.repc.2017.07.009","volume":"37","author":"S Araujo","year":"2018","unstructured":"Araujo S, Rouxinol-Dias A, Mesquita-Bastos J, Silva J, Barbosa L, Polonia J. Ambulatory blood pressure monitoring profiles in a cross-sectional analysis of a large database of normotensive and true or suspected hypertensive patients. Rev Port Cardiol (Engl Ed). 2018;37(4):319\u201327.","journal-title":"Rev Port Cardiol (Engl Ed)"},{"issue":"4","key":"2766_CR22","doi-asserted-by":"publisher","first-page":"e13224","DOI":"10.1111\/ctr.13224","volume":"32","author":"SF Yalin","year":"2018","unstructured":"Yalin SF, Trabulus S, Seyahi N, Cengiz M, Cicik ME, Altiparmak MR. Ambulatory blood pressure monitoring in living kidney donors: what changes in 10 years? Clin Transpl. 2018;32(4):e13224.","journal-title":"Clin Transpl"},{"issue":"4","key":"2766_CR23","first-page":"127","volume":"65","author":"AM Birkenhager","year":"2007","unstructured":"Birkenhager AM, van den Meiracker AH. Causes and consequences of a non-dipping blood pressure profile. Neth J Med. 2007;65(4):127\u201331.","journal-title":"Neth J Med"},{"issue":"16","key":"2766_CR24","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1016\/j.lfs.2004.08.034","volume":"76","author":"M Zeman","year":"2005","unstructured":"Zeman M, Dulkova K, Bada V, Herichova I. Plasma melatonin concentrations in hypertensive patients with the dipping and non-dipping blood pressure profile. Life Sci. 2005;76(16):1795\u2013803.","journal-title":"Life Sci"},{"issue":"3","key":"2766_CR25","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/ajh.2009.252","volume":"23","author":"A Myredal","year":"2010","unstructured":"Myredal A, Friberg P, Johansson M. Elevated myocardial repolarization lability and arterial baroreflex dysfunction in healthy individuals with nondipping blood pressure pattern. Am J Hypertens. 2010;23(3):255\u20139.","journal-title":"Am J Hypertens"},{"issue":"12","key":"2766_CR26","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1097\/HJH.0b013e3282f06428","volume":"25","author":"AS Astrup","year":"2007","unstructured":"Astrup AS, Nielsen FS, Rossing P, Ali S, Kastrup J, Smidt UM, et al. Predictors of mortality in patients with type 2 diabetes with or without diabetic nephropathy: a follow-up study. J Hypertens. 2007;25(12):2479\u201385.","journal-title":"J Hypertens"},{"issue":"9594","key":"2766_CR27","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1016\/S0140-6736(07)61538-4","volume":"370","author":"J Boggia","year":"2007","unstructured":"Boggia J, Li Y, Thijs L, Hansen TW, Kikuya M, Bjorklund-Bodegard K, et al. Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study. Lancet. 2007;370(9594):1219\u201329.","journal-title":"Lancet"},{"issue":"1","key":"2766_CR28","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/ajh.2007.7","volume":"21","author":"DJ Brotman","year":"2008","unstructured":"Brotman DJ, Davidson MB, Boumitri M, Vidt DG. Impaired diurnal blood pressure variation and all-cause mortality. Am J Hypertens. 2008;21(1):92\u20137.","journal-title":"Am J Hypertens"},{"issue":"1","key":"2766_CR29","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1161\/01.HYP.0000170138.56903.7a","volume":"46","author":"E Dolan","year":"2005","unstructured":"Dolan E, Stanton A, Thijs L, Hinedi K, Atkins N, McClory S, et al. Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: the Dublin outcome study. Hypertension. 2005;46(1):156\u201361.","journal-title":"Hypertension"},{"issue":"11","key":"2766_CR30","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1016\/j.jacc.2011.04.043","volume":"58","author":"RC Hermida","year":"2011","unstructured":"Hermida RC, Ayala DE, Mojon A, Fernandez JR. Decreasing sleep-time blood pressure determined by ambulatory monitoring reduces cardiovascular risk. J Am Coll Cardiol. 2011;58(11):1165\u201373.","journal-title":"J Am Coll Cardiol"},{"issue":"1\u20132","key":"2766_CR31","doi-asserted-by":"publisher","first-page":"68","DOI":"10.3109\/07420528.2012.702581","volume":"30","author":"RC Hermida","year":"2013","unstructured":"Hermida RC, Ayala DE, Fernandez JR, Mojon A. Sleep-time blood pressure: prognostic value and relevance as a therapeutic target for cardiovascular risk reduction. Chronobiol Int. 2013;30(1\u20132):68\u201386.","journal-title":"Chronobiol Int"},{"issue":"1","key":"2766_CR32","doi-asserted-by":"publisher","first-page":"e3","DOI":"10.1161\/HYPERTENSIONAHA.111.00249","volume":"61","author":"RC Hermida","year":"2013","unstructured":"Hermida RC, Ayala DE, Mojon A, Fernandez JR, Smolensky M, Portaluppi F. Morning surge, dipping, and sleep-time blood pressure as prognostic markers of cardiovascular risk. Hypertension. 2013;61(1):e3.","journal-title":"Hypertension"},{"issue":"9","key":"2766_CR33","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.2337\/diabetes.47.9.1501","volume":"47","author":"S Nakano","year":"1998","unstructured":"Nakano S, Fukuda M, Hotta F, Ito T, Ishii T, Kitazawa M, et al. Reversed circadian blood pressure rhythm is associated with occurrences of both fatal and nonfatal vascular events in NIDDM subjects. Diabetes. 1998;47(9):1501\u20136.","journal-title":"Diabetes"},{"issue":"11","key":"2766_CR34","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1097\/00004872-200211000-00017","volume":"20","author":"T Ohkubo","year":"2002","unstructured":"Ohkubo T, Hozawa A, Yamaguchi J, Kikuya M, Ohmori K, Michimata M, et al. Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama study. J Hypertens. 2002;20(11):2183\u20139.","journal-title":"J Hypertens"},{"issue":"5","key":"2766_CR35","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1046\/j.1464-5491.2000.00284.x","volume":"17","author":"ND Sturrock","year":"2000","unstructured":"Sturrock ND, George E, Pound N, Stevenson J, Peck GM, Sowter H. Non-dipping circadian blood pressure and renal impairment are associated with increased mortality in diabetes mellitus. Diabet Med. 2000;17(5):360\u20134.","journal-title":"Diabet Med"},{"issue":"1","key":"2766_CR36","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s41669-022-00364-0","volume":"7","author":"KK Shah","year":"2023","unstructured":"Shah KK, Willson M, Agresta B, Morton RL. Cost effectiveness of ambulatory blood pressure monitoring compared with home or clinic blood pressure monitoring for diagnosing hypertension in Australia. Pharmacoecon Open. 2023;7(1):49\u201362.","journal-title":"Pharmacoecon Open"},{"issue":"4","key":"2766_CR37","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1161\/01.HYP.0000158261.86674.8e","volume":"45","author":"V Kotsis","year":"2005","unstructured":"Kotsis V, Stabouli S, Bouldin M, Low A, Toumanidis S, Zakopoulos N. Impact of obesity on 24-hour ambulatory blood pressure and hypertension. Hypertension. 2005;45(4):602\u20137.","journal-title":"Hypertension"},{"issue":"3","key":"2766_CR38","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1097\/HJH.0000000000002283","volume":"38","author":"B Lyu","year":"2020","unstructured":"Lyu B, Hagen EW, Ravelo LA, Peppard PE. Blood pressure dipping and sleep quality in the Wisconsin Sleep Cohort. J Hypertens. 2020;38(3):448\u201355.","journal-title":"J Hypertens"},{"issue":"4","key":"2766_CR39","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.smrv.2012.09.005","volume":"17","author":"AN Vgontzas","year":"2013","unstructured":"Vgontzas AN, Fernandez-Mendoza J, Liao D, Bixler EO. Insomnia with objective short sleep duration: the most biologically severe phenotype of the disorder. Sleep Med Rev. 2013;17(4):241\u201354.","journal-title":"Sleep Med Rev"},{"issue":"1","key":"2766_CR40","first-page":"19","volume":"12","author":"M Jonas","year":"2003","unstructured":"Jonas M, Garfinkel D, Zisapel N, Laudon M, Grossman E. Impaired nocturnal melatonin secretion in non-dipper hypertensive patients. Blood Press. 2003;12(1):19\u201324.","journal-title":"Blood Press"},{"issue":"6","key":"2766_CR41","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1002\/ajmg.a.35915","volume":"161A","author":"GD Leschziner","year":"2013","unstructured":"Leschziner GD, Golding JF, Ferner RE. Sleep disturbance as part of the neurofibromatosis type 1 phenotype in adults. Am J Med Genet A. 2013;161A(6):1319\u201322.","journal-title":"Am J Med Genet A"},{"issue":"5538","key":"2766_CR42","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1126\/science.1063097","volume":"293","author":"JA Williams","year":"2001","unstructured":"Williams JA, Su HS, Bernards A, Field J, Sehgal A. A circadian output in Drosophila mediated by neurofibromatosis-1 and Ras\/MAPK. Science. 2001;293(5538):2251\u20136.","journal-title":"Science"},{"issue":"13","key":"2766_CR43","doi-asserted-by":"publisher","first-page":"3416","DOI":"10.1016\/j.celrep.2018.03.014","volume":"22","author":"L Bai","year":"2018","unstructured":"Bai L, Lee Y, Hsu CT, Williams JA, Cavanaugh D, Zheng X, et al. A conserved circadian function for the neurofibromatosis 1 gene. Cell Rep. 2018;22(13):3416\u201326.","journal-title":"Cell Rep"},{"issue":"10","key":"2766_CR44","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1590\/0004-282X20160122","volume":"74","author":"LG Madeira","year":"2016","unstructured":"Madeira LG, Passos RL, Souza JF, Rezende NA, Rodrigues LO. Autonomic thermoregulatory dysfunction in neurofibromatosis type 1. Arq Neuropsiquiatr. 2016;74(10):796\u2013802.","journal-title":"Arq Neuropsiquiatr"},{"issue":"11","key":"2766_CR45","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1093\/hmg\/ddl114","volume":"15","author":"F Li","year":"2006","unstructured":"Li F, Munchhof AM, White HA, Mead LE, Krier TR, Fenoglio A, et al. Neurofibromin is a novel regulator of RAS-induced signals in primary vascular smooth muscle cells. Hum Mol Genet. 2006;15(11):1921\u201330.","journal-title":"Hum Mol Genet"},{"issue":"19","key":"2766_CR46","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1161\/CIRCULATIONAHA.107.707752","volume":"116","author":"J Xu","year":"2007","unstructured":"Xu J, Ismat FA, Wang T, Yang J, Epstein JA. NF1 regulates a ras-dependent vascular smooth muscle proliferative injury response. Circulation. 2007;116(19):2148\u201356.","journal-title":"Circulation"},{"issue":"3","key":"2766_CR47","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1097\/00125817-200205000-00002","volume":"4","author":"JM Friedman","year":"2002","unstructured":"Friedman JM, Arbiser J, Epstein JA, Gutmann DH, Huot SJ, Lin AE, et al. Cardiovascular disease in neurofibromatosis 1: report of the NF1 Cardiovascular Task Force. Genet Med. 2002;4(3):105\u201311.","journal-title":"Genet Med"},{"issue":"27","key":"2766_CR48","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1056\/NEJM198112313052704","volume":"305","author":"VM Riccardi","year":"1981","unstructured":"Riccardi VM. Von Recklinghausen neurofibromatosis. N Engl J Med. 1981;305(27):1617\u201327.","journal-title":"N Engl J Med"},{"issue":"4","key":"2766_CR49","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1530\/EJE-16-0233","volume":"175","author":"L Kepenekian","year":"2016","unstructured":"Kepenekian L, Mognetti T, Lifante JC, Giraudet AL, Houzard C, Pinson S, et al. Interest of systematic screening of pheochromocytoma in patients with neurofibromatosis type 1. Eur J Endocrinol. 2016;175(4):335\u201344.","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"2766_CR50","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1136\/jmg.2004.021683","volume":"41","author":"RE Ferner","year":"2004","unstructured":"Ferner RE, Hughes RA, Hall SM, Upadhyaya M, Johnson MR. Neurofibromatous neuropathy in neurofibromatosis 1 (NF1). J Med Genet. 2004;41(11):837\u201341.","journal-title":"J Med Genet"},{"key":"2766_CR51","doi-asserted-by":"crossref","unstructured":"Neurofibromatosis. Conference statement. National Institutes of Health Consensus Development Conference. Arch Neurol. 1988;45(5):575-8.","DOI":"10.1001\/archneur.1988.00520290115023"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-023-02766-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-023-02766-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-023-02766-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,24]],"date-time":"2023-06-24T01:48:43Z","timestamp":1687571323000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-023-02766-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,23]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2766"],"URL":"https:\/\/doi.org\/10.1186\/s13023-023-02766-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2318392\/v1","asserted-by":"object"}]},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,23]]},"assertion":[{"value":"28 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Ethical institutional review board Committee of the Complejo Asistencial Universitario de Le\u00f3n (approval number 1060) approved the study protocol. All study participants provided written consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All patients provided their written consent to participate in this publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors state that they have no competing interests to declare. None of the authors accepted any reimbursements, fees or funds from any organization that may in any way gain or loses financially from the results of this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"164"}}